NIA AD/ADRD R01 Research Grant
Funds investigator-led United States research programs on Alzheimer's disease and related dementias.
PAR-25-332, titled Research on Current Topics in Alzheimer's Disease and AD-Related Dementias (R01 Clinical Trial Optional), is NIA's primary parent NOFO for investigator-initiated R01 research grants in the AD/ADRD space. Released December 30, 2024 and expiring November 6, 2027, the parent NOFO hosts a series of Notices of Special Interest (NOSIs) that define the high-priority topic areas eligibl…
Investigator-initiated research on current priority topics in Alzheimer's disease and related dementias, as defined by active NOSIs attached to PAR-25-332.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline